Valuation (59%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 11.17 | N/A |
PEG Ratio (TTM) | -1.97 | N/A |
P/S Ratio (TTM) | 0.63 | N/A |
P/B Ratio (TTM) | 5.84 | N/A |
P/FCF Ratio (TTM) | -15.70 | N/A |
Price to 5YR AVG Earnings Ratio | 24.06 | N/A |
Price to 5YR AVG FCF Ratio | 15.01 | N/A |
Profitability (70%) |
Company | Industry |
---|---|---|
ROA (TTM) | 12.52% | N/A |
ROE (TTM) | 55.30% | N/A |
Net Profit Margin (TTM) | 5.77% | N/A |
ROIC 5YR AVG | 29.74% | N/A |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -3.48% | -19.20% | 9.60% |
Revenue | 1.77% | 3.21% | 8.35% |
Net Income | -4.18% | -15.06% | 5.10% |
Cash Flow | -70.16% | -2,278.17% | -776.49% |
Health (86%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.63 | N/A |
Quick Ratio (TTM) | 1.63 | N/A |
D/E Ratio (TTM) | 1.01 | N/A |
Interest Coverage (TTM) | 12.22 | N/A |
Piotroski F-Score | 6 | N/A |
Altman Z-Score | 4.11 | N/A |
LTL to 5YR AVG FCF | 2.90 | N/A |
Shares Outstanding Growth 5YR AVG | -7.32% | N/A |